TABLE 2.
Clinical characteristics, electrocardiographic data, echocardiographic data, and coronary angiographic data according to cut‐off values of fQRS‐T and PLR.
| Group I (HfHP) (n = 189) | Group II (HfLP or LfHP) (n = 237) | Group III (LfLP) (n = 212) | p | |
|---|---|---|---|---|
| Age (years) | 62.71 ± 11.90 | 58.83 ± 13.24 | 57.08 ± 11.57 | .030 |
| Sex (M/F) | 147/42 | 187/50 | 168/44 | .933 |
| Hypertension (%) | 94 (49.7) | 116 (48.9) | 94 (44.3) | .492 |
| Diabetes mellitus (%) | 52 (27.5) | 48 (20.3) | 52 (24.5) | .208 |
| Hyperlipidemia (%) | 40 (21.2) | 52 (21.9) | 42 (19.8) | .856 |
| PAD (%) | 2 (1.1) | 6 (2.5) | 10 (4.7) | .082 |
| I‐CMP (%) | 81 (42.9) | 56 (23.6) | 38 (17.9) | .001 |
| LVEF (%) | 45.00 (35.00–50.00) | 45.00 (40.00–54.00) | 45.00 (40.00–55.00) | .016 |
| Troponin (ng/mL) | 50.00 (30.00–68.00) | 39.79 (15.56–64.15) | 37.40 (9.25–50.00) | .005 |
| Creatinine (mg/dL) | 0.94 (0.77–1.09) | 0.87 (0.73–0.99) | 0.88 (0.77–1.01) | .036 |
| eGFR (mL/min/1.73 m2) | 86.10 (72.50–108.00) | 91.00 (75.00–105.00) | 94.00 (77.00–109.00) | .293 |
| LDL‐C (mg/dL) | 117.00 (96.75–149.50) | 113.00 (97.80–145.00) | 110.00 (84.40–134.00) | .001 |
| HDL‐C (mg/dL) | 36.00 (32.00–47.00) | 39.00 (34.00–45.70) | 38.00 (32.85–46.00) | .123 |
| fQRS‐T (°) | 118.00 (87.49–147.00) | 47.00 (25.44–77.04) | 31.93 (17.30–47.19) | .001 |
| Hematological parameters | ||||
| Hemoglobin (g/dL) | 13.20 (12.10–14.60) | 14.00 (12.70–14.80) | 14.10 (12.90–15.10) | .004 |
| WBC (×10/μL) | 11.61 (9.00–15.00) | 11.90 (9.59–14.38) | 11.66 (9.20–14.30) | .548 |
| Neutrophil count (×103/μL) | 9.20 (6.72–12.55) | 8.78 (6.80–10.95) | 6.87 (5.50–10.10) | .001 |
| Lymp. count (×103/μL) | 1.50 (1.00–1.90) | 2.00 (1.30–2.60) | 2.52 (1.80–3.70) | .001 |
| Platelet count (×103/μL) | 243.00 (195.00–277.00) | 241.00 (213.00–284.00) | 225.00 (190.00–265.00) | .004 |
| PLR | 166.87 (132.10–266.66) | 124.58 (94.58–182.30) | 63.48 (40.25–83.24) | .001 |
| Angiographic parameters | ||||
| Proximal lesion (%) | 94 (49.7) | 134 (56.5) | 102 (48.1) | .165 |
| Three vessel disease (%) | 39 (20.6) | 39 (16.5) | 34 (16.0) | .412 |
| TIMI flow grade | 2.49 ± 0.92 | 2.71 ± 0.67 | 2.72 ± 0.68 | .001 |
Abbreviations: eGFR, estimated glomerular filtration rate; fQRS‐T, frontal plane QRS‐T angle; HDL‐C, high density lipoprotein cholesterol; HfHP, high fQRS‐T and high platelet‐to‐lymphocyte ratio; HfLP, high fQRS‐T and low platelet‐to‐lymphocyte ratio; I‐CMP, ischemic cardiomyopathy; LDL‐C, low density lipoprotein cholesterol; LfHP, low fQRS‐T and high platelet‐to‐lymphocyte ratio; LfLP, low fQRS‐T and low platelet‐to‐lymphocyte ratio; LVEF, left ventricular ejection fraction; Lymp., lymphocyte; PAD, peripheral arterial disease; PLR, platelet‐to‐lymphocyte ratio; TIMI, thrombolysis in myocardial infarction; WBC, white blood counts.